Target intelligence / Profile preview

Novel transcript, antisense to C14orf101

Molecular classification: Long non-coding RNA (lncRNA)

Overview

The transcript ENSG00000258428, referred to as "novel transcript, antisense to C14orf101", is a human long non-coding RNA (lncRNA), mapped antisense to the protein-coding gene C14orf101 on chromosome 14. This locus has no protein product, known function, or disease relevance in current biomedical databases, and is not included in drug-gene or therapeutic target repositories. It primarily appears in transcriptome annotations as a predicted, uncharacterized lncRNA with unknown relevance for cell biology or disease.

Other names: AL161757.2

Biological functions

Unknown/Other

Disease associations

Other

Beyond the preview

Go deeper on Novel transcript, antisense to C14orf101.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to C14orf101.

Explore the full profile